J&J | JNJ - Ebitda


J&J reported $8.27B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Abbott USD 2.43B 844M Mar/2026
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Baxter International USD -447M 873M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Biogen USD 649.7M 76.5M Mar/2026
Boston Scientific USD 1.16B 213M Dec/2025
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
CONMED USD 56.39M 23.97M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Eli Lilly USD 12.14B 4.26B Dec/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merck USD 6.3B 2.09B Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 939M 101M Dec/2025